Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For whatever reason they are clearly holding this back today.
EAPH - GOLDEN CROSS SIGNAL REACHED TODAY!
Some people think this will mean a 50% upwards slingshot affect.
My guess would be more specific details about the California deal. Probably more revenue/financial related.
Completely agree. Should already be $.10 then go higher from there based on Canadian developments.
I agree. EAPH has a completely different feel to it. Even when the stock starts to dip, buying jumps in and brings it right back. Feel like it has consolidated very well and ready for a huge jump in stock price. God bless EAPH!
Very well said Constant. We are going up and have all the momentum without any news. If we get it, so be it.
All this other talk of needing to sell and buy in and sell and buy in......whatever. All of you have fun with that. I will just sit here and be happy with my 500,000 shares and watch it go up in value. IMO, no one needs to do that because more and more new people are going to keep buying in. The word will keep getting out there and there will be exponential buying.
Looking for another 100,000 when my money clears in my account Monday. EAPH LONG!
Nice!!!!
You're going to do that one time and then the stock will just keep going and not drop back down.
OR JUST BUY IT, HOLD IT AND DON'T WORRY ABOUT IT!
Agreed. No other company even comes close. It will happen!
One of the worst presidents the US has ever had. Long EAPH!!!!
I'm patient but very annoyed. If this same news came out a year ago, we would have sky rocketed to $1. Now it comes out and not much of an impact. I guess the market has changed and we now need to prove ourselves and show actual revenue/profit. Shouldn't be a problem at all but will just take a little longer than expected. Confident this will be a $0.25 stock this year and one of only a few mj penny companies to succeed. LONG EAPH!
Heard from who?
I am in for 500,000. Buying 100,000 more tomorrow or Monday when my money clears.
Makes no sense. You tell us. The day isn't over yet though. I think it will finish over $.03. Just my gut.
Yes, bottom line anyone with half a brain can look for themselves and see that we are extremely undervalued. The most conservative estimate you could possibly come up with puts us well over $.10 per share. The market will catch up and realize this.
EAPH: REVISED REVENUE CALCULATION FROM EARLIER POST
10,000 plants will be grown per year x 3 harvests. Each plant yields 1 lbs. Marijuana is going for approximately $2,500/lb. We have a 40% ownership.
10,000 x 3 harvests x 1 lbs x $2,500/lbs x .4 = $30,000,000 per year.
Lets now say very conservatively they will make 50% profit on this and the other 50% goes towards overhead. This would mean Easton will make $15,000,000 per year.
750,000,000 outstanding shareS = $.02 per share profit x 20 multiplier = $.40 per share. EAPH SHOULD BE WORTH $.40 PER SHARE imo.
This doesn't even take into account any other products or deals. This doesn't take into account future expansion!
You are correct. Just researched this. 500 grams or 1 pound per plant. Want to get this right.
REVISED REVENUE CALCULATION
10,000 plants will be grown per year x 3 harvests. Each plant yields 1 lbs. Marijuana is going for approximately $2,500/lb. We have a 40% ownership.
10,000 x 3 harvests x 1 lbs x $2,500/lbs x .4 = $30,000,000 per year.
Lets now say very conservatively they will make 50% profit on this and the other 50% goes towards overhead. This would mean Easton will make $15,000,000 per year.
750,000,000 outstanding shareS = $.02 per share profit x 20 multiplier = $.40 per share. EAPH SHOULD BE WORTH $.40 PER SHARE imo.
This doesn't even take into account any other products or deals. This doesn't take into account future expansion!
REVISED REVENUE BASED ON 750,000,000 SHARES. LETS JUST MAKE IT 800,000,000 shares and be conservative:
REVENUE CALCULATION
Ok, per post by Krex, here are the new figures:
10,000 plants will be grown per year x 3 harvests. Each plant yields 4 lbs. Marijuana is going for approximately $2,500/lb. We have a 40% ownership.
10,000 x 3 harvests x 4 lbs x $2,500/lbs x .4 = $120,000,000 per year.
Lets now say very conservatively they will make 50% profit on this and the other 50% goes towards overhead. This would mean Easton will make $60,000,000 per year. Yes, 60 million.
800,000,000 outstanding shares = $.075 per share profit x 20 multiplier = $1.50 per share. EAPH SHOULD BE WORTH $1.50 PER SHARE imo.
This doesn't even take into account any other products or deals. This doesn't take into account future expansion!
What am I missing? At the very least should be breaking year highs and be at $.10 right now!!!!!
Either I am missing something here or we are all going to be completely rich.
EAPH is currently valued at $.029. They just partnered with a California medical marijuana company that grows 10,000 plants. See the following revenue calculation and tell me what I am missing:
REVENUE CALCULATION
Ok, per post by Krex, here are the new figures:
10,000 plants will be grown per year x 3 harvests. Each plant yields 4 lbs. Marijuana is going for approximately $2,500/lb. We have a 40% ownership.
10,000 x 3 harvests x 4 lbs x $2,500/lbs x .4 = $120,000,000 per year.
Lets now say very conservatively they will make 50% profit on this and the other 50% goes towards overhead. This would mean Easton will make $60,000,000 per year. Yes, 60 million.
580,000,000 outstanding shares = $.10 per share profit x 20 multiplier = $2 per share. EAPH SHOULD BE WORTH $2 PER SHARE imo.
This doesn't even take into account any other products or deals. This doesn't take into account future expansion!
REVENUE CALCULATION
Ok, per post by Krex, here are the new figures:
10,000 plants will be grown per year x 3 harvests. Each plant yields 4 lbs. Marijuana is going for approximately $2,500/lb. We have a 40% ownership.
10,000 x 3 harvests x 4 lbs x $2,500/lbs x .4 = $120,000,000 per year.
Lets now say very conservatively they will make 50% profit on this and the other 50% goes towards overhead. This would mean Easton will make $60,000,000 per year. Yes, 60 million.
580,000,000 outstanding shares = $.10 per share profit x 20 multiplier = $2 per share. EAPH SHOULD BE WORTH $2 PER SHARE imo.
This doesn't even take into account any other products or deals. This doesn't take into account future expansion!
So if we all assume they get to a point to where the company makes 5 million in profit with 580 million shares outstanding, this would put them at .0086 per share profit. Then using a standard 20 multiplier, this would put our share price at $0.17. I think anyone can see being 5 million profitable is very obtainable for them.
If you then look at the Canadian deal, their other products and expansion of the California facility, I believe one can see where they could easily in a few years be making 50 million and a share price at $1.70. Not a make believe scenario.......could really happen if they play their cards right and make the right moves imo.
So as we sit here today, our share price is $.029? Come on market......wake up! Way undervalued! A freaking penny stock that for once has a chance to really make it! Not many penny stocks ever make it. This one can and will imo.
So when you see someone on this board throw out the $1 per share and think they are crazy, looks like maybe they are not crazy?
You can't just go by share price. Each company ahs a different number of shares outstanding. Have to compare market caps.
So ridiculous.....EAPH is valued at 1/3 of FIT-. Makes no sense.
This is a $0.10 stock right now! I hope people figure this out!
I agree. Just frustrating. Believe me........I have been patient for almost a year now and will continue to be.
I really don't get it. Total buzz kill. I am long either way but this should be up over .05 already.
Anyone who sold is absolutely ridiculous. These same people will buy back in at a higher price.........if they are smart anyways. Going back up......the weak hands losing money!
GCHAMMER SAYS: STRONG BUY RATING FOR EAPH!!!!!! $.10 SHORT TERM, $.25 LONG TERM
EAPH - I told everyone over a week ago this company would be huge. Now from yesterday's news, signed deal and 40% ownership in California medical marijuana grower. 3 to 4 bag potential over the next week or so imo. Possibly one of the only real plays in the marijuana sector. If not the only, the best play imo.
EAPH - Signed deal with California medical marijuana grower. They now have a 40% stake in the company. Potential 3 to 4 bagger in a week imo.
I agree ConstantinCC. .05 is way low. I do not think people even realize yet how huge the news was yesterday. Anyone out there that follows mj stocks will want to buy in and have a piece of this........as they should. In all honesty, we should be at new highs already and it would be completely justified. No more hype driving this stock......now it is a real business model....now it is fact! Finally now, people can trust Easton. I admit, over the past year I had my doubts from time to time. Now, all you can say is they came through for us and the company. This is real and the stock price should be showing it is real. Right now today, we should be at .10 in my opinion and "hype" should be pushing the share price to .15+. EVERYONE......Spread the news on other boards and sites!!!!!
Not that it means anything but my prediction is huge run up after 1:00 pm right into the close. Close at .032. Then tomorrow .035 close. Hope I am right. This is so under valued in my opinion it isn't even funny. I would NEVER sell one single share at these stupid prices.
IMO .10 to .15 is a near lock within the next month. What a beautiful day!
EAPH NEWS IS OUT!!!!!! Hang on for a HUGE ride!!!!!
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
Jan 20, 2015
OTC Disclosure & News Service
-
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
TORONTO, ON--(Marketwired - Jan 20, 2015) - Easton Pharmaceuticals Inc. (OTC: EAPH) Signs Finalized agreement with Medicated Markets International LLC., a major California medical marijuana grower in a restricted share swap agreement. Up to 25% of Easton restricted stock, rights to use Easton's transdermal matrix technologies, and One hundred thousand dollars; to be exchanged for 40% of Medicated Markets International LLC.
Easton Pharmaceuticals has been searching to enter the highly Lucrative Medical Marijuana Grower market within legalized jurisdictions. Medicated Markets International LLC, is a current grower / cultivator located in the City of Perris, California, (20 acres) Riverside county and one main growing location in Mendocino County, California with a total actual growing area of approximately 3 acres. Medicated Markets has been looking to buy assets in Canada, including submission of their own MMPR application to Health Canada, or by buying a controlling interest in an already Licensed Provider. A growing US economy as well as strong Medical Marijuana demand In California, while Canadian assets have been falling has made this opportunity and agreement to be a great benefit for both companys.
The recent sharp drop in the Canadian Dollar was also a driving factor in the completion of this deal, as Canadian assets have become much more attractive at discounted rates in US Dollar terms. Easton's US partners have shown great interest in diversifying through Joint venture operations in Canada centered on patient acquisition as well as transdermal medication delivery and associated product launch. Details on these initiatives in both US and Canadian markets should be ready for disclosure by early next week. The two Medicated Markets Califiornia Master grower License numbers are #B8377788, and #330471333. More pictures of current mother plants used for cloning, dispensary cash receipts as well as grow location addresses will be available at https://twitter.com/medimarkets in the coming days.
Medical cannabis is commonly used to self-treat severe pain associated with Cancer, arthritis, musculoskeletal pain and other ailments. As of June 2014, estimates from the office of Information Commissioner of Canada list "severe arthritis" as the main reason 65% of Canadians are possessing marijuana for medicinal purposes. Proposed initiatives hope to eventually allow the transdermal delivery of medicinal marijuana to a patient's area of pain, without having to inhale through the lungs. Currently McGill University, McMaster University, and University of Guelph have ongoing research projects into Medical Marijuana in Canada.
The Medical Marijuana Movement in North America started in California, which was the first state to establish a medical marijuana program, enacted by Proposition 215 in 1996 and Senate Bill 420 in 2003. Prop. 215, also known as the Compassionate Use Act, was approved by an initiative with a 55% majority, allowing people with cancer, AIDS and other chronic illnesses the right to grow or obtain marijuana for medical purposes when recommended by a doctor. SB 420, or the Medical Marijuana Protection Act, was signed into law by Governor Gray Davis and established an identification card system for medical marijuana patients. Marijuana advocates are hopeful that if they can get a legalization measure on the ballot in California in 2016, it will pass and federal reform will follow shortly afterwards.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company previously owned an FDA approved wound healing drug and currently owns topically-delivered drugs to treat cancer and other conditions that are in various stages of development with 3 of its OTC products to soon be ready for marketing and sale. Easton has completed an acquisition that grants a 40% ownership interest in Medicated Markets International LLC; a California Licensed Medical Marijuana Grower on 20 acres (3 acre growing area). Easton has also made additional investments into AMFIL Technologies and their groZONE anti-microbial airflow system, and have an exclusive option to purchase up to 49% in a medical marijuana grow-op business post granting of license from Health Canada, located in Ontario, Canada which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
https://twitter.com/medimarkets
http://ecigmarkets.com/
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact:
Carla Pepe
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
Copyright © 2015 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
It took them a LONG time but yes they did!
EAPH NEWS JUST CAME OUT!!!!!!
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
Jan 20, 2015
OTC Disclosure & News Service
-
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
TORONTO, ON--(Marketwired - Jan 20, 2015) - Easton Pharmaceuticals Inc. (OTC: EAPH) Signs Finalized agreement with Medicated Markets International LLC., a major California medical marijuana grower in a restricted share swap agreement. Up to 25% of Easton restricted stock, rights to use Easton's transdermal matrix technologies, and One hundred thousand dollars; to be exchanged for 40% of Medicated Markets International LLC.
Easton Pharmaceuticals has been searching to enter the highly Lucrative Medical Marijuana Grower market within legalized jurisdictions. Medicated Markets International LLC, is a current grower / cultivator located in the City of Perris, California, (20 acres) Riverside county and one main growing location in Mendocino County, California with a total actual growing area of approximately 3 acres. Medicated Markets has been looking to buy assets in Canada, including submission of their own MMPR application to Health Canada, or by buying a controlling interest in an already Licensed Provider. A growing US economy as well as strong Medical Marijuana demand In California, while Canadian assets have been falling has made this opportunity and agreement to be a great benefit for both companys.
The recent sharp drop in the Canadian Dollar was also a driving factor in the completion of this deal, as Canadian assets have become much more attractive at discounted rates in US Dollar terms. Easton's US partners have shown great interest in diversifying through Joint venture operations in Canada centered on patient acquisition as well as transdermal medication delivery and associated product launch. Details on these initiatives in both US and Canadian markets should be ready for disclosure by early next week. The two Medicated Markets Califiornia Master grower License numbers are #B8377788, and #330471333. More pictures of current mother plants used for cloning, dispensary cash receipts as well as grow location addresses will be available at https://twitter.com/medimarkets in the coming days.
Medical cannabis is commonly used to self-treat severe pain associated with Cancer, arthritis, musculoskeletal pain and other ailments. As of June 2014, estimates from the office of Information Commissioner of Canada list "severe arthritis" as the main reason 65% of Canadians are possessing marijuana for medicinal purposes. Proposed initiatives hope to eventually allow the transdermal delivery of medicinal marijuana to a patient's area of pain, without having to inhale through the lungs. Currently McGill University, McMaster University, and University of Guelph have ongoing research projects into Medical Marijuana in Canada.
The Medical Marijuana Movement in North America started in California, which was the first state to establish a medical marijuana program, enacted by Proposition 215 in 1996 and Senate Bill 420 in 2003. Prop. 215, also known as the Compassionate Use Act, was approved by an initiative with a 55% majority, allowing people with cancer, AIDS and other chronic illnesses the right to grow or obtain marijuana for medical purposes when recommended by a doctor. SB 420, or the Medical Marijuana Protection Act, was signed into law by Governor Gray Davis and established an identification card system for medical marijuana patients. Marijuana advocates are hopeful that if they can get a legalization measure on the ballot in California in 2016, it will pass and federal reform will follow shortly afterwards.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company previously owned an FDA approved wound healing drug and currently owns topically-delivered drugs to treat cancer and other conditions that are in various stages of development with 3 of its OTC products to soon be ready for marketing and sale. Easton has completed an acquisition that grants a 40% ownership interest in Medicated Markets International LLC; a California Licensed Medical Marijuana Grower on 20 acres (3 acre growing area). Easton has also made additional investments into AMFIL Technologies and their groZONE anti-microbial airflow system, and have an exclusive option to purchase up to 49% in a medical marijuana grow-op business post granting of license from Health Canada, located in Ontario, Canada which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
https://twitter.com/medimarkets
http://ecigmarkets.com/
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact:
Carla Pepe
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
Copyright © 2015 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
EAPH NEWS OUT!!!!!!!!!
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
Jan 20, 2015
OTC Disclosure & News Service
-
Easton Pharmaceuticals Inc Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, a Major California Based Medical Marijuana Grower
TORONTO, ON--(Marketwired - Jan 20, 2015) - Easton Pharmaceuticals Inc. (OTC: EAPH) Signs Finalized agreement with Medicated Markets International LLC., a major California medical marijuana grower in a restricted share swap agreement. Up to 25% of Easton restricted stock, rights to use Easton's transdermal matrix technologies, and One hundred thousand dollars; to be exchanged for 40% of Medicated Markets International LLC.
Easton Pharmaceuticals has been searching to enter the highly Lucrative Medical Marijuana Grower market within legalized jurisdictions. Medicated Markets International LLC, is a current grower / cultivator located in the City of Perris, California, (20 acres) Riverside county and one main growing location in Mendocino County, California with a total actual growing area of approximately 3 acres. Medicated Markets has been looking to buy assets in Canada, including submission of their own MMPR application to Health Canada, or by buying a controlling interest in an already Licensed Provider. A growing US economy as well as strong Medical Marijuana demand In California, while Canadian assets have been falling has made this opportunity and agreement to be a great benefit for both companys.
The recent sharp drop in the Canadian Dollar was also a driving factor in the completion of this deal, as Canadian assets have become much more attractive at discounted rates in US Dollar terms. Easton's US partners have shown great interest in diversifying through Joint venture operations in Canada centered on patient acquisition as well as transdermal medication delivery and associated product launch. Details on these initiatives in both US and Canadian markets should be ready for disclosure by early next week. The two Medicated Markets Califiornia Master grower License numbers are #B8377788, and #330471333. More pictures of current mother plants used for cloning, dispensary cash receipts as well as grow location addresses will be available at https://twitter.com/medimarkets in the coming days.
Medical cannabis is commonly used to self-treat severe pain associated with Cancer, arthritis, musculoskeletal pain and other ailments. As of June 2014, estimates from the office of Information Commissioner of Canada list "severe arthritis" as the main reason 65% of Canadians are possessing marijuana for medicinal purposes. Proposed initiatives hope to eventually allow the transdermal delivery of medicinal marijuana to a patient's area of pain, without having to inhale through the lungs. Currently McGill University, McMaster University, and University of Guelph have ongoing research projects into Medical Marijuana in Canada.
The Medical Marijuana Movement in North America started in California, which was the first state to establish a medical marijuana program, enacted by Proposition 215 in 1996 and Senate Bill 420 in 2003. Prop. 215, also known as the Compassionate Use Act, was approved by an initiative with a 55% majority, allowing people with cancer, AIDS and other chronic illnesses the right to grow or obtain marijuana for medical purposes when recommended by a doctor. SB 420, or the Medical Marijuana Protection Act, was signed into law by Governor Gray Davis and established an identification card system for medical marijuana patients. Marijuana advocates are hopeful that if they can get a legalization measure on the ballot in California in 2016, it will pass and federal reform will follow shortly afterwards.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company previously owned an FDA approved wound healing drug and currently owns topically-delivered drugs to treat cancer and other conditions that are in various stages of development with 3 of its OTC products to soon be ready for marketing and sale. Easton has completed an acquisition that grants a 40% ownership interest in Medicated Markets International LLC; a California Licensed Medical Marijuana Grower on 20 acres (3 acre growing area). Easton has also made additional investments into AMFIL Technologies and their groZONE anti-microbial airflow system, and have an exclusive option to purchase up to 49% in a medical marijuana grow-op business post granting of license from Health Canada, located in Ontario, Canada which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
https://twitter.com/medimarkets
http://ecigmarkets.com/
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact:
Carla Pepe
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
Copyright © 2015 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Congrats Easton! Great job!
Sorry......meant 9:00 to 9:30. Not 8. Their last press release came out at exactly 9:30 am at the opening bell.